The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Open accessAbstract
BACKGROUND: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults. METHODS: We enrolled 38,546 adults 60 years of age or older in a randomized, double-blind, placebo-controlled trial of an investigational live attenuated Oka/Merck VZV vaccine ("zoster vaccine"). Herpes zoster was diagnosed according to clinical and laboratory criteria. The pain and discomfort associated with herpes zoster were measured repeatedly for six months. The primary end point was the burden of illness due to herpes zoster, a measure affected by the incidence, severity, and duration of the associated pain and discomfort. The secondary end point was the incidence of postherpetic neuralgia. RESULTS: More than 95 percent of the subjects continued in the study to its completion, with a median of 3.12 years of surveillance for herpes zoster. A total of 957 confirmed cases of herpes zoster (315 among vaccine recipients and 642 among placebo recipients) and 107 cases of postherpetic neuralgia (27 among vaccine recipients and 80 among placebo recipients) were included in the efficacy analysis. The use of the zoster vaccine reduced the burden of illness due to herpes zoster by 61.1 percent (P<0.001), reduced the incidence of postherpetic neuralgia by 66.5 percent (P<0.001), and reduced the incidence of herpes zoster by 51.3 percent (P<0.001). Reactions at the injection site were more frequent among vaccine recipients but were generally mild. CONCLUSIONS: The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A live-attenuated vaccine is available, which has been shown to reduce the incidence of herpes zoster by 51.3% (95% CI: 44.2–57.6) and of post-herpetic neuralgia, a severe complication occurring frequently in the elderly, by 66.5% (95% CI: 44.5–79.2) in the vaccinated population compared to placebo [170].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
In the citing paper
“The protective effect against post-herpetic neuralgia was independent of age, whereas clinical efficacy against herpes zoster declined to only 27.6% in persons older than 69 years.”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,389
Comparative analysis of two rates
Miettinen, O. S., & Nurminen, M. M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,111
Population-Based Study of Herpes Zoster and Its Sequelae
Ragozzino, M. W., Melton, L. J., Kurland, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 921
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Self-citationTesting the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire
Brazier, J. E., Jones, N., & Kind, P. (1993) · Quality of Life Research · doi:10.1007/bf00435221 · Cited by 707
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Self-citationThe Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430150071008 · Cited by 618
Research works printed but not linked: 2
- Hope-Simpson RE, 1965, Proc R Soc Med, 58, 9
- Hope-Simpson RE, 1975, J R Coll Gen Pract, 25, 571
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Immune Correlates of Herpes Zoster in HIV-Infected Children and Youth
Weinberg, A., Huang, S., Song, L., Fenton, T., Williams, P. L., Patterson, J., Tovar-Salazar, A., & Levin, M. J. (2011) · Journal of Virology · doi:10.1128/jvi.06623-11 · Cited by 22
Self-citationBirlea, M., Owens, G. P., Eshleman, E. M., Ritchie, A. M., Traktinskiy, I., Bos, N., Seitz, S., Azarkh, Y., Mahalingam, R., Gilden, D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02561-12 · Cited by 22
Chen, J.-Y., Cheng, T., Chang, C., Lan, K.-M., Weng, S., Sheu, M.-J., Tseng, S.-F., & Hu, M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt213 · Cited by 22
Immunization Against Viral Diseases
Ledgerwood, J. E., & Graham, B. S. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch17 · Cited by 22
Tyring, S. K., Lee, P. J., Hill, G., Silverfield, J. C., Moore, A. Y., Matkovits, T., & SULLIVAN-BOLYAI, J. Z. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24750 · Cited by 22
Varicella Virus Vaccination in the United States
Shaw, J., & Gershon, A. A. (2017) · Viral Immunology · doi:10.1089/vim.2017.0136 · Cited by 22
Self-citationWatanabe, D., Mizukami, A., Holl, K., Curran, D., Oorschot, D. V., Varghese, L., & Shiragami, M. (2018) · Dermatology and Therapy · doi:10.1007/s13555-018-0236-3 · Cited by 22
Nugent, Z. J., Singh, H., Targownik, L. E., & Bernstein, C. N. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy249 · Cited by 22
Furuto, Y., Kawamura, M., Namikawa, A., Takahashi, H., & Shibuya, Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4193-y · Cited by 22
Hehir, M. K., & Logigian, E. L. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000455881.83803.a9 · Cited by 22
McKinnon, J. E., & Maksimowicz‐McKinnon, K. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.008 · Cited by 23
Gomi, Y., Ozaki, T., Nishimura, N., Narita, A., Suzuki, M., Ahn, J., Watanabe, N., Koyama, N., Ushida, H., Yasuda, N., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.069 · Cited by 22
Takao, Y., Miyazaki, Y., Onishi, F., Kumihashi, H., Gomi, Y., Ishikawa, T., Okuno, Y., Mori, Y., Asada, H., Yamanishi, K., et al. (2012) · Journal of Epidemiology · doi:10.2188/jea.je20110035 · Cited by 22
The current state of vaccine development for ocular HSV-1 infection
Royer, D. J., Cohen, A. W., & Carr, D. J. J. (2015) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.1004315 · Cited by 22
Herpes Zoster and Postherpetic Neuralgia
Schmader, K. E., & Dworkin, R. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00028-0 · Cited by 22
Self-citationFardet, L., Rybojad, M., Gain, M., Kettaneh, A., Cherin, P., Bachelez, H., Dubertret, L., Lebbé, C., Morel, P., & Dupuy, A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.152 · Cited by 22
Cohen, J. I. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00137-5 · Cited by 22
Brisson, M., Pellissier, J. M., & Levin, M. J. (2007) · Clinical Infectious Diseases · doi:10.1086/523011 · Cited by 22
Self-citationBuccoliero, G. B., Lonero, G., Romanelli, C., Loperfido, P., & Resta, F. (2010) · PubMed · Cited by 21
Herpes zoster vaccine: What are the potential benefits for the ageing and older adults?
Lang, P.-O., & Michel, J. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.06.001 · Cited by 21
Johnson, M. J., Liu, C., Ghosh, D., Lang, N., Levin, M. J., & Weinberg, A. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab580 · Cited by 21
Self-citationWilhour, D., & Nahas, S. J. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0880-0 · Cited by 21
A randomised sham-controlled study evaluating rTMS analgesic efficacy for postherpetic neuralgia
Wang, H., Hu, Y., Deng, J., Yang, Y., Huang, M., Che, X., & Liang, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1158737 · Cited by 23
Silverii, G. A., Clerico, A., Fornengo, R., Gabutti, G., Sordi, V., Peruzzi, O., Tafuri, S., Mannucci, E., & Dicembrini, I. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02127-7 · Cited by 52
Burden of herpes zoster and post-herpetic neuralgia in Sweden
Nilsson, J., Cassel, T. N., & Lindquist, L. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0951-7 · Cited by 21
Chen, J., Wang, L., Feng, P.-H., Chu, C., Cheng, T., Weng, S., Wu, S.-Z., Lu, T., & Chang, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134930 · Cited by 21
Balasubramaniam, R., & Klasser, G. D. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.007 · Cited by 21
Meysman, P., Ogunjimi, B., Naulaerts, S., Beutels, P., Tendeloo, V. F. V., & Laukens, K. (2014) · Journal of Virology · doi:10.1128/jvi.02500-14 · Cited by 21
Bravo, T. P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0552-2 · Cited by 21
Herpes Zoster Associated Hospital Admissions in Italy: Review of the Hospital Discharge Forms
Gabutti, G., Serenelli, C., Cavallaro, A., & Ragni, P. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6092344 · Cited by 21
Herpes zoster and vaccination: A clinical review
Adams, E. N., Parnapy, S., & Bautista, P. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090118 · Cited by 21
One-year follow-up of patients with long-lasting post-herpetic neuralgia
Pica, F., Gatti, A., Divizia, M., Lazzari, M., Ciotti, M., Sabato, A. F., & Volpi, A. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0556-6 · Cited by 21
Roh, N. K., Park, Y. M., Kang, H., Choi, G. S., Kim, B. J., Lee, Y. W., Lew, B., & Sim, W. (2015) · Annals of Dermatology · doi:10.5021/ad.2015.27.5.531 · Cited by 21
López-Belmonte, J. L., Cisterna, R., de Miguel, Á. G., Guilmet, C., Bianic, F., & Uhart, M. (2016) · Journal of Medical Economics · doi:10.3111/13696998.2016.1146726 · Cited by 21
Ward, C., Byrne, L., White, J. M., Amirthalingam, G., Tiley, K. S., & Edelstein, M. L. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.042 · Cited by 21
Management of Corneal Scarring Secondary to Herpes Zoster Keratitis
Hassan, O. M., Farooq, A. V., Soin, K., Djalilian, A. R., & Hou, J. H. (2017) · Cornea · doi:10.1097/ico.0000000000001235 · Cited by 21
Zoch-Lesniak, B., Tolksdorf, K., & Siedler, A. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1446718 · Cited by 21
STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE
Laupland, K. B. (2010) · Canada Communicable Disease Report · doi:10.14745/ccdr.v36i00a01 · Cited by 21
Vaccine Development for Varicella-Zoster Virus
Sadaoka, T., & Mori, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-7230-7_7 · Cited by 20
de Boer, P. T., van Lier, A., de Melker, H. E., van Wijck, A. J. M., Wilschut, J., van Hoek, A. J., & Postma, M. J. (2018) · BMC Medicine · doi:10.1186/s12916-018-1213-5 · Cited by 21
Gershon, A. A., Marin, M., & Seward, J. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00062-6 · Cited by 22
Self-citationGershon, A. A., Takahashi, M., & Seward, J. F. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50039-8 · Cited by 21
Self-citationFunctional decline and herpes zoster in older people: an interplay of multiple factors
Herpes Zoster and Functional Decline Consortium (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0450-0 · Cited by 21
Presentation and management of herpes zoster (shingles) in the geriatric population.
Cohen, K., Salbu, R. L., Frank, J., & Israel, I. (2013) · Europe PMC (PubMed Central) · Cited by 21
Díaz, C., Dentico, P., González, R., Méndez, R., Cinquetti, S., Barben, J. L., Harmon, A., Chalikonda, I., Smith, J. G., Stek, J. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.030 · Cited by 21
Self-citationMeduri, A., Grenga, P., & Kaufman, S. C. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.45 · Cited by 21
Herpes zoster: epidemiology, clinical features, treatment and prevention
Wehrhahn, M. C., & Dwyer, D. E. (2012) · Australian Prescriber · doi:10.18773/austprescr.2012.067 · Cited by 21
Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications
Capuron, L., Miller, A. H., & Irwin, M. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50030-7 · Cited by 22
Self-citationWhitley, R. J. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00137-5 · Cited by 21
Varicella vaccines and measles, mumps, rubella, and varicella vaccine
Bricks, L. F., Sato, H. K., & Oselka, G. W. (2006) · Jornal de Pediatria · doi:10.2223/jped.1496 · Cited by 21
Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent
Stylianou, V. V., Bertram, K. M., Vo, V. A., Dunn, E. B., Baharlou, H., Terre, D. D., Elhindi, J., Elder, E. E., French, J. R., Meybodi, F., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174144 · Cited by 23
Senderovich, H., Grewal, J. K., & Mujtaba, M. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1600482 · Cited by 20
Systematic Review and Meta-analysis of Herpes Zoster Vaccine in Patients With CKD
Hamad, M. A., Allam, H., Sulaiman, A., Murali, K., & Hassan, H. I. C. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.02.024 · Cited by 20
Min, J.-Y., Mwakingwe-Omari, A., Riley, M. E., Molo, L. Y., Soni, J., Girard, G., & Danier, J. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.12.033 · Cited by 20
Dendritic cells as Achilles’ heel and Trojan horse during varicella zoster virus infection
Schönrich, G., & Raftery, M. J. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00417 · Cited by 20
Live attenuated herpes zoster vaccine for HIV ‐infected adults
Shafran, S. D. (2015) · HIV Medicine · doi:10.1111/hiv.12311 · Cited by 20
New viral vaccines for dermatologic disease
Urman, C., & Gottlieb, A. B. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.07.051 · Cited by 20
Overcoming barriers to adult immunization.
High, K. P. (2009) · PubMed · Cited by 20
Hata, A., Inoue, F., Hamamoto, Y., Yamasaki, M., Fujikawa, J., Kawahara, H., Kawasaki, Y., Honjo, S., Koshiyama, H., Moriishi, E., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.13038 · Cited by 20
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
Davies, S. C., Hussein, I. M., Nguyen, T. M., Parker, C. E., Khanna, R., & Jairath, V. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012381.pub2 · Cited by 20
Jamani, K., MacDonald, J. C., Lavoie, M., Williamson, T. S., Brown, C. B., Chaudhry, A. M., Jimenez-Zepeda, V. H., Duggan, P. R., Tay, J., Stewart, D. A., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000836 · Cited by 20
Gershon, A. A., Takahashi, M., & Seward, J. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00042-2 · Cited by 21
Self-citationPrice, N. B., & Grose, C. F. (2021) · Vaccines · doi:10.3390/vaccines9010023 · Cited by 20
Top 100 Most-Cited Papers in Neuropathic Pain From 2000 to 2020: A Bibliometric Study
Xiong, H.-Y., Liu, H., & Wang, X. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.765193 · Cited by 20
Kleemann, P. P., Distler, E., Wagner, E. M., Thomas, S., Klobuch, S., Aue, S., Schnürer, E., Schild, H., Theobald, M., Plachter, B., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.052597 · Cited by 20
Stanberry, L. R., & Strugnell, R. A. (2011) · Perspectives in Vaccinology · doi:10.1016/j.pervac.2011.05.006 · Cited by 20
Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
Whitley, R. J. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00139-9 · Cited by 20
Immunizations in the elderly: do they live up to their promise?
Herndler‐Brandstetter, D., Cioca, D., & Grubeck‐Loebenstein, B. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-006-0267-8 · Cited by 20
Herpes zoster with progression to acute varicella zoster virus‐meningoencephalitis
Braun‐Falco, M., & Hoffmann, M. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.04023.x · Cited by 20
Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia
Betts, R. F. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.017 · Cited by 20
Self-citationModeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age
Li, X., Zhang, J. H., Betts, R. F., Morrison, V. A., Xu, R., Itzler, R. F., Acosta, C. J., Dasbach, E. J., Pellissier, J. M., Johnson, G. R., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.039 · Cited by 19
Self-citationShiraki, K., Toyama, N., Shiraki, A., & Yajima, M. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.01.009 · Cited by 19
Al-Orini, D., Alshoshan, A. A., Almutiri, A. O., Almreef, A. A., Alrashidi, E. S., Almutiq, A. M., Noman, R., & Al‐Wutayd, O. (2023) · Vaccines · doi:10.3390/vaccines11030651 · Cited by 19
Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
Tortellini, E., Ngangue, Y. C. F., Dominelli, F., Guardiani, M., Falvino, C., Mengoni, F., Carraro, A., Marocco, R., Pasculli, P., Mastroianni, C. M., et al. (2023) · Viruses · doi:10.3390/v15091844 · Cited by 24
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
Anastassopoulou, C. G., Ferous, S., Medić, S., Siafakas, N., Boufidou, F., Gioula, G., & Tsakris, A. (2024) · Vaccines · doi:10.3390/vaccines12060566 · Cited by 21
Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes.
Mortensen, G. L. (2011) · PubMed · Cited by 19
Preaud, E., Uhart, M., Böhm, K., Aidelsburger, P., Anger, D., Bianic, F., & Largeron, N. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011561 · Cited by 19
Management and Prevention of Herpes Zoster: A Canadian Perspective
Boivin, G., Jovey, R. D., Elliott, C. T., & Patrick, D. M. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/178036 · Cited by 19
Gutzeit, C., Raftery, M. J., Peiser, M., Tischer, B. K., Ulrich, M., Eberhardt, M., Stockfleth, E., Giese, T., Sauerbrei, A., Morita, C. T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902817 · Cited by 19
Vaccines for the elderly need to be introduced into the immunization program in India
Verma, R. K., Khanna, P., & Chawla, S. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29254 · Cited by 19
Duracinský, M., Paccalin, M., Gavazzi, G., Kebir, S. E., Gaillat, J., Strady, C., Bouhassira, D., & Chassany, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-529 · Cited by 19
Meyer, C., Kerns, A. R., Haberthur, K., Dewane, J., Walker, J. M., Gray, W. L., & Messaoudi, I. (2012) · Journal of Virology · doi:10.1128/jvi.02369-12 · Cited by 19
Liu, J., Zhu, R., Ye, X., Yang, L., Wang, Y., Huang, Y., Wu, J. F., Wang, W., Ye, J., Li, Y., et al. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6602-5 · Cited by 19
Self-citationAdult health checkup: Update on the Preventive Care Checklist Form©.
Ridley, J., Ischayek, A., Dubey, V., & Iglar, K. (2012) · Europe PMC (PubMed Central) · Cited by 19
Assessing the introduction of universal varicella vaccination in the Netherlands
Boot, H. J., de Melker, H. E., Stolk, E. A., de Wit, G. A., & Kimman, T. G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.071 · Cited by 19
Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds
Ogunjimi, B., Buntinx, F., Bartholomeeusen, S., Terpstra, I., haes, I. D., Willem, L., Elli, S., Bilcke, J., Damme, P. V., Coenen, S., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.08.016 · Cited by 19
PHN group, Rullán, M., Bulilete, O., Leiva, A., Soler, A., Roca, A., González-Bals, M. J., Lorente, P., & Llobera, J. (2017) · Trials · doi:10.1186/s13063-016-1729-y · Cited by 19
Crosbie, B., Lucey, S., Tilson, L., Domegan, L. M., & Kieran, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3153-y · Cited by 19
Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus
Kocaoğlu, G., Utine, C. A., Yaman, A., & Men, S. (2018) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.02256 · Cited by 19
Matthews, I. R., Lu, X., Dawson, H., Bricout, H., O'Hanlon, H., Yu, E., & Nozad, B. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.037 · Cited by 19
Lu, P.-J., Hung, M.-C., Srivastav, A., Williams, W. W., & Dooling, K. L. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.01.017 · Cited by 19
Differential Approaches for Vaccination from Childhood to Old Age
Prelog, M. (2012) · Gerontology · doi:10.1159/000343475 · Cited by 19
Reducing the burden of Herpes Zoster in Italy
Gabutti, G., Franco, E., Bonanni, P., Conversano, M., Ferro, A. M., Lazzari, M., Maggi, S., Rossi, A., Scotti, S., Vitale, F. M., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34363 · Cited by 19
Wilck, M. B., & Baden, L. R. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328307c7c5 · Cited by 19
Quantitative Measurement of Varicella-Zoster Virus Infection by Semiautomated Flow Cytometry
Gates, I. V., Zhang, Y., Shambaugh, C., Bauman, M. A., Tan, C. Y., & Bodmer, J.-L. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02006-08 · Cited by 19
Nutritional Factors in Herpes Zoster, Postherpetic Neuralgia, and Zoster Vaccination
Chen, J., Chang, C., Lin, Y., & Hu, M. (2012) · Population Health Management · doi:10.1089/pop.2012.1563 · Cited by 19
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Verma, A. (2006) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)70305-3 · Cited by 19
FV100 as a new approach for the possible treatment of varicella-zoster virus infection
McGuigan, C., & Balzarini, J. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp294 · Cited by 19
Perspective on Live Varicella Vaccine
Gershon, A. A., & Katz, S. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/522151 · Cited by 19
Self-citationLee, W. B., & Liesegang, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06387-6.00087-8 · Cited by 19
Metadata
- Authors
- Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, J. H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., Kauffman, C. A., Pachucki, C. T., Neuzil, K. M., Betts, R. F., Wright, P. F., Griffin, M. R., Brunell, P., Soto, N. E., Marques, A. R., Keay, S. K., Goodman, R. P., Cotton, D. J., Gnann, J. W., Loutit, J., Holodniy, M., Keitel, W. A., Crawford, G. E., Yeh, S.-S., Lobo, Z., Toney, J. F., Greenberg, R. N., Keller, P. M., Harbecke, R., Hayward, A. R., Irwin, M. R., Kyriakides, T. C., Chan, C. Y., Chan, I. S. F., Wang, W. W. B., Annunziato, P. W., & Silber, J. L.
- Affiliations
- University of California San Diego (US)
- Durham VA Medical Center (US)
- Duke Medical Center (US)
- National Institutes of Health (US)
- Washington University in St. Louis (US)
- VA Boston Healthcare System (US)
- VA NY Harbor Healthcare System (US)
- Columbia University (US)
- New Mexico VA Health Care System (US)
- National Institute of Allergy and Infectious Diseases (US)
- VA San Diego Healthcare System (US)
- VA Ann Arbor Healthcare System (US)
- Edward Hines, Jr. VA Hospital (US)
- VA Puget Sound Health Care System (US)
- University of Rochester Medicine (US)
- Vanderbilt University Medical Center (US)
- Baltimore VA Medical Center (US)
- VA Palo Alto Health Care System (US)
- Baylor College of Medicine (US)
- The University of Texas at San Antonio Health Science Center (US)
- Northport VA Medical Center (US)
- James A. Haley Veterans' Hospital (US)
- Lexington VA Health Care System (US)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-06-02
- Volume
- 352
- Issue
- 22
- Pages
- 2271-2284
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131041950
- Cited by
- 2,412
- References
- 40
- Citations by year
- 2026: 51 · 2025: 90 · 2024: 63 · 2023: 92 · 2022: 60 · 2021: 95 · 2020: 97 · 2019: 111 · 2018: 145 · 2017: 155 · 2016: 158 · 2015: 133 · 2014: 126 · 2013: 149 · 2012: 110
- FWCI
- 89.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- herpes zoster, postherpetic neuralgia, varicella-zoster virus, live attenuated zoster vaccine, older adults, vaccine efficacy, disease burden, cell-mediated immunity, injection site reactions
- MeSH terms
- Aged, Double-Blind Method, Female, Follow-Up Studies, Herpes Zoster, Humans, Immunologic Memory, Male, Middle Aged, Neuralgia, Vaccines, Attenuated, Herpesvirus 3, Human, Virus Activation, Incidence, Cost of Illness, Chickenpox Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
